APA (7th ed.) Citation

Abbas, A. E. F., Abdelshafi, N. A., Gamal, M., Halim, M. K., Said, B. A. M., Naguib, I. A., . . . Salem, Y. A. (2024). Simultaneously quantifying a novel five-component anti- migraine formulation containing ergotamine, propyphenazone, caffeine, camylofin, and mecloxamine using UV spectrophotometry and chemometric models. BMC chemistry, 18(1), 233-21. https://doi.org/10.1186/s13065-024-01339-4

Chicago Style (17th ed.) Citation

Abbas, Ahmed Emad F., Nahla A. Abdelshafi, Mohammed Gamal, Michael K. Halim, Basmat Amal M. Said, Ibrahim A. Naguib, Mohmeed M. A. Mansour, Samir Morshedy, and Yomna A. Salem. "Simultaneously Quantifying a Novel Five-component Anti- Migraine Formulation Containing Ergotamine, Propyphenazone, Caffeine, Camylofin, and Mecloxamine Using UV Spectrophotometry and Chemometric Models." BMC Chemistry 18, no. 1 (2024): 233-21. https://doi.org/10.1186/s13065-024-01339-4.

MLA (9th ed.) Citation

Abbas, Ahmed Emad F., et al. "Simultaneously Quantifying a Novel Five-component Anti- Migraine Formulation Containing Ergotamine, Propyphenazone, Caffeine, Camylofin, and Mecloxamine Using UV Spectrophotometry and Chemometric Models." BMC Chemistry, vol. 18, no. 1, 2024, pp. 233-21, https://doi.org/10.1186/s13065-024-01339-4.